Literature DB >> 18172002

Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.

Ofir Menashe1, Elena Kaganskaya, Timor Baasov, Sima Yaron.   

Abstract

The high antibacterial activity and selectivity of aminoglycosides and their low activity against intracellular bacteria associated with eukaryotic cells make them the antibiotics of choice for the elimination of extracellular bacteria during intracellular studies. Given the evidence that aminoglycosides can penetrate the eukaryotic cell membrane, the goal of this study was to examine the influence of aminoglycosides on macrophage-associated Salmonella. Herein, we show that gentamicin, kanamycin, and tobramycin at concentrations between 15 to 150 microg ml(-1) do not kill intracellular Salmonella but have other effects on the bacterial physiology. By using Salmonella enterica serovars Typhimurium and Virchow harboring luciferase reporter plasmid, we observed that the light produced by intracellular Salmonella declined immediately upon exposure to aminoglycosides, indicating that the bacteria were under stress. The extent of this effect was dependent on the macrophage host, on the identity of the aminoglycoside and its concentration, on the exposure time, and on the Salmonella serovar. Salmonella associated with Nramp1-negative macrophages, in which the phagosomal pH is higher, were more susceptible to aminoglycosides than Salmonella associated with Nramp1-expressing macrophages. These results verify that aminoglycosides affect intracellular bacteria and that the extent of this effect is dependent on the acidity level within the phagosome, suggesting that for the study of intracellular bacteria, the aminoglycoside concentration should be limited to two to five times the MIC for the bacterial strain studied. This precaution should guarantee the complete execution of extracellular bacteria with minimal effects on the intracellular bacteria and the host cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18172002      PMCID: PMC2258524          DOI: 10.1128/AAC.00382-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  42 in total

1.  Structural basis for selectivity and toxicity of ribosomal antibiotics.

Authors:  E C Böttger; B Springer; T Prammananan; Y Kidan; P Sander
Journal:  EMBO Rep       Date:  2001-04       Impact factor: 8.807

2.  Microarray-based detection of Salmonella enterica serovar Typhimurium transposon mutants that cannot survive in macrophages and mice.

Authors:  Kaman Chan; Charles C Kim; Stanley Falkow
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  The presence of the tet gene from cloning vectors impairs Salmonella survival in macrophages.

Authors:  Stephanie Abromaitis; Sébastien Faucher; Maxime Béland; Roy Curtiss; France Daigle
Journal:  FEMS Microbiol Lett       Date:  2005-01-15       Impact factor: 2.742

Review 4.  Molecular insights into aminoglycoside action and resistance.

Authors:  Sophie Magnet; John S Blanchard
Journal:  Chem Rev       Date:  2005-02       Impact factor: 60.622

5.  Aptamers that preferentially bind type IVB pili and inhibit human monocytic-cell invasion by Salmonella enterica serovar typhi.

Authors:  Qin Pan; Xiao-Lian Zhang; Hong-Yan Wu; Pan-Wen He; Fubin Wang; Ming-Sheng Zhang; Jian-Ming Hu; Bing Xia; Jianguo Wu
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

6.  Visualization of vacuolar acidification-induced transcription of genes of pathogens inside macrophages.

Authors:  Natalia Martin-Orozco; Nicolas Touret; Michael L Zaharik; Edwin Park; Raoul Kopelman; Samuel Miller; B Brett Finlay; Philippe Gros; Sergio Grinstein
Journal:  Mol Biol Cell       Date:  2005-10-26       Impact factor: 4.138

7.  Survival of nontypeable Haemophilus influenzae in macrophages.

Authors:  J E Craig; A Cliffe; K Garnett; N J High
Journal:  FEMS Microbiol Lett       Date:  2001-09-11       Impact factor: 2.742

8.  Salmonella enterica serotype Virchow: epidemiology, resistance patterns and molecular characterisation of an invasive Salmonella serotype in Israel.

Authors:  M Weinberger; H Solnik-Isaac; D Shachar; A Reisfeld; L Valinsky; N Andorn; V Agmon; R Yishai; R Bassal; A Fraser; S Yaron; D Cohen
Journal:  Clin Microbiol Infect       Date:  2006-10       Impact factor: 8.067

9.  sciS, an icmF homolog in Salmonella enterica serovar Typhimurium, limits intracellular replication and decreases virulence.

Authors:  Duncan A Parsons; Fred Heffron
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

10.  Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.

Authors:  Maritza Barcia-Macay; Cristina Seral; Marie-Paule Mingeot-Leclercq; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

View more
  18 in total

1.  Sensitization of intracellular Salmonella enterica serovar Typhimurium to aminoglycosides in vitro and in vivo by a host-targeted antimicrobial agent.

Authors:  Jung-Hsin Lo; Samuel K Kulp; Ching-Shih Chen; Hao-Chieh Chiu
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

2.  Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay.

Authors:  Mohamad A Hamad; Alexander M Skeldon; Miguel A Valvano
Journal:  Appl Environ Microbiol       Date:  2010-03-26       Impact factor: 4.792

3.  Use of Carbapenems against clinical, nontyphoid Salmonella isolates: results from in vitro and in vivo animal studies.

Authors:  Hung-Jen Tang; Chi-Chung Chen; Chun-Cheng Zhang; Kuo Chen Cheng; Shyh-Ren Chiang; Yu-Hsin Chiu; Yee Huang Ku; Wen-Chien Ko; Yin-Ching Chuang
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

4.  Nitric oxide protects bacteria from aminoglycosides by blocking the energy-dependent phases of drug uptake.

Authors:  Bruce D McCollister; Matthew Hoffman; Maroof Husain; Andrés Vázquez-Torres
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

5.  A TRP Channel Senses Lysosome Neutralization by Pathogens to Trigger Their Expulsion.

Authors:  Yuxuan Miao; Guojie Li; Xiaoli Zhang; Haoxing Xu; Soman N Abraham
Journal:  Cell       Date:  2015-05-28       Impact factor: 41.582

6.  Impact of gentamicin-supplemented polyvinylidenfluoride mesh materials on MMP-2 expression and tissue integration in a transgenic mice model.

Authors:  Marcel Binnebösel; Christina Ricken; Christian D Klink; Karsten Junge; Marc Jansen; Volker Schumpelick; Petra Lynen Jansen
Journal:  Langenbecks Arch Surg       Date:  2010-02-13       Impact factor: 3.445

7.  In vitro and in vivo intracellular killing effects of tigecycline against clinical nontyphoid Salmonella isolates using ceftriaxone as a comparator.

Authors:  Hung-Jen Tang; Wen-Chien Ko; Chi-Chung Chen; Po-Lin Chen; Han Siong Toh; Tzu Chieh Weng; Wen-Liang Yu; Shyh-Ren Chiang; Yin-Ching Chuang
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

8.  Alternative Enzyme Protection Assay To Overcome the Drawbacks of the Gentamicin Protection Assay for Measuring Entry and Intracellular Survival of Staphylococci.

Authors:  Jin-Hahn Kim; Akhilesh Kumar Chaurasia; Nayab Batool; Kwan Soo Ko; Kyeong Kyu Kim
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

9.  Intracellular Listeria monocytogenes comprises a minimal but vital fraction of the intestinal burden following foodborne infection.

Authors:  Grant S Jones; Kate M Bussell; Tanya Myers-Morales; Abigail M Fieldhouse; Elsa N Bou Ghanem; Sarah E F D'Orazio
Journal:  Infect Immun       Date:  2015-05-26       Impact factor: 3.441

10.  Amoebae as potential environmental hosts for Mycobacterium ulcerans and other mycobacteria, but doubtful actors in Buruli ulcer epidemiology.

Authors:  Sophie Gryseels; Diana Amissah; Lies Durnez; Koen Vandelannoote; Herwig Leirs; Johan De Jonckheere; Manuel T Silva; Françoise Portaels; Anthony Ablordey; Miriam Eddyani
Journal:  PLoS Negl Trop Dis       Date:  2012-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.